NICOPASS FRESH MINT 1.5 Base Milligrams Lozenges Ірландія - англійська - HPRA (Health Products Regulatory Authority)

nicopass fresh mint 1.5 base milligrams lozenges

pierre fabre medicament - nicotine resinate - lozenges - 1.5 base milligrams

NICOPASS FRESH MINT 2.5 Milligram Lozenges Ірландія - англійська - HPRA (Health Products Regulatory Authority)

nicopass fresh mint 2.5 milligram lozenges

pierre fabre medicament - nicotine - lozenges - 2.5 milligram

NICOPASS LIQUORICE MINT 1.5 Base Milligrams Lozenges Ірландія - англійська - HPRA (Health Products Regulatory Authority)

nicopass liquorice mint 1.5 base milligrams lozenges

pierre fabre medicament - nicotine resinate - lozenges - 1.5 base milligrams

NICOPASS LIQUORICE MINT 2.5 Milligram Lozenges Ірландія - англійська - HPRA (Health Products Regulatory Authority)

nicopass liquorice mint 2.5 milligram lozenges

pierre fabre medicament - nicotine - lozenges - 2.5 milligram

PECTODRILL FOR CHESTY COUGHS 250/5 Mg/Ml Oral Solution Ірландія - англійська - HPRA (Health Products Regulatory Authority)

pectodrill for chesty coughs 250/5 mg/ml oral solution

pierre fabre medicament - carbocisteine - oral solution - 250/5 mg/ml

TOPAAL CHEWABLE TABLETS 30/40/200/ Milligram Tablets Chewable Ірландія - англійська - HPRA (Health Products Regulatory Authority)

topaal chewable tablets 30/40/200/ milligram tablets chewable

pierre fabre medicament - aluminium hydroxide gel, dried magnesium carbonate light alginic acid silica colloidal hydrated - tablets chewable - 30/40/200/ milligram

TUSSIDRILL SUGAR-FREE FOR DRY COUGHS 15mg/5ml Mg/Ml Oral Solution Ірландія - англійська - HPRA (Health Products Regulatory Authority)

tussidrill sugar-free for dry coughs 15mg/5ml mg/ml oral solution

pierre fabre medicament - dextromethorphan hydrobromide - oral solution - 15mg/5ml mg/ml

Braftovi Європейський Союз - англійська - EMA (European Medicines Agency)

braftovi

pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastic agents - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy

Mektovi Європейський Союз - англійська - EMA (European Medicines Agency)

mektovi

pierre fabre medicament - binimetinib - melanoma - antineoplastic agents - binimetinib in combination with encorafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation.

Nerlynx Європейський Союз - англійська - EMA (European Medicines Agency)

nerlynx

pierre fabre medicament - neratinib - breast neoplasms - antineoplastic agents - nerlynx is indicated for the extended adjuvant treatment of adult patients with early stage hormone receptor positive her2-overexpressed/amplified breast cancer and who are less than one year from the completion of prior adjuvant trastuzumab based therapy.